Despite the measures implemented in 2010 by the National Patient Safety Agency (NPSA) in the United Kingdom to reduce insulin prescription errors, the National Diabetes Inpatient Audit has revealed high levels of errors associated with insulin prescriptions [5,6]. The gene discussed is INS; the disease is diabetes mellitus.